Clinical Trials Directory

Trials / Completed

CompletedNCT02195726

Efficacy of RIPC to Reduce AKI for Patients Undergoing PCI

The EUROpean and Asian Cardiac and Renal Remote Ischemic Pre-conditioning Study : A Prospective, Randomized Control Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,110 (actual)
Sponsor
A.O.U. Città della Salute e della Scienza · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of the present study is to determine if remote ischemic preconditioning reduces incidence of acute kidney injury in patients with reduced kidney function undergoing Percutaneous Coronary Intervention.

Detailed description

Acute kidney injury negatively impacts on prognosis after PCI, and only hydratation have shown to reduce this complication. Remote ischemic preconditioning has been demonstrated to reduce periprocedural MI, while impact on aki remains to be assessed

Conditions

Interventions

TypeNameDescription
PROCEDURERemote ischemic preconditioningfour times 5-minute inflations of a blood pressure cuff to 200 mmHg around the upper non dominant arm (or if systolic pressure is more than 150 mmHg, inflation will reach 50 mmHg up per than baseline), followed by 5-minute intervals of reperfusion.
PROCEDURESham remote ischemic preconditioningIn the control group sham preconditioning will be performed with inflation of 10 mmHg more than baseline.

Timeline

Start date
2013-01-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2014-07-21
Last updated
2014-07-21

Locations

7 sites across 3 countries: France, Italy, Spain

Source: ClinicalTrials.gov record NCT02195726. Inclusion in this directory is not an endorsement.